Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.

myTempleHealth
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Associated Press Interviews Dr. Terry Heiman-Patterson about Relyvrio, the Third Medication Approved in the United States for ALS

View All News

The Associated Press interviewed Terry Heiman-Patterson, MD, Professor of Neurology at the Lewis Katz School of Medicine at Temple University and Director of the Temple MDA/ALS Center of Hope, for an article about Relyvrio. Relyvrio is only the third medication approved in the United States for ALS, or amyotrophic lateral sclerosis. Fortune picked up the Associated Press article.